Menu
Back to Journals » Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
- View all (417)
- Volume 10, 2017 (43)
- Volume 9, 2016 (45)
- Volume 8, 2015 (59)
- Volume 7, 2014 (61)
- Volume 6, 2013 (50)
- Volume 5, 2012 (41)
- Volume 4, 2011 (46)
- Volume 3, 2010 (45)
- Volume 2, 2009 (22)
- Volume 1, 2008 (5)
Journal Articles:
- 417 records -
Online continuing medical education as a key link for successful noncommunicable disease self-management: the CASALUD™ Model
Gallardo-Rincón H, Saucedo-Martínez R, Mujica-Rosales R, Lee EM, Israel A, Torres-Beltran B, Quijano-González Ú, Atkinson ER, Kuri-Morales P, Tapia-Conyer R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:443-455
Published Date: 16 October 2017
Awareness of diabetic retinopathy among patients with type 2 diabetes mellitus in Jordan
Bakkar MM, Haddad MF, Gammoh YS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:435-441
Published Date: 11 October 2017
Cardiac autonomic neuropathy in patients with diabetes mellitus: current perspectives
Fisher VL, Tahrani AA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:419-434
Published Date: 6 October 2017
Weight loss medications in Canada – a new frontier or a repeat of past mistakes?
Wharton S, Lee J, Christensen RAG
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:413-417
Published Date: 4 October 2017
Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes
Sikirica MV, Martin AA, Wood R, Leith A, Piercy J, Higgins V
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:403-412
Published Date: 29 September 2017
Metabolic syndrome remission after Roux-en-Y gastric bypass or sleeve gastrectomy
Nassour I, Almandoz JP, Adams-Huet B, Kukreja S, Puzziferri N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:393-402
Published Date: 20 September 2017
Hypertriglyceridemic waist phenotype in primary health care: comparison of two cutoff points
Braz MAD, Vieira JN, Gomes FO, Silva PR, Santos OTM, Rocha IMGD, Sousa IMD, Fayh APT
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:385-391
Published Date: 12 September 2017
Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges
Chiquette E, Oral EA, Garg A, Araújo-Vilar D, Dhankhar P
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:375-383
Published Date: 13 September 2017
Type 2 diabetes in Vietnam: a cross-sectional, prevalence-based cost-of-illness study
Le NTD, Dinh Pham L, Quang Vo T
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:363-374
Published Date: 29 August 2017
Novel biomarkers for prediabetes, diabetes, and associated complications
Dorcely B, Katz K, Jagannathan R, Chiang SS, Oluwadare B, Goldberg IJ, Bergman M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:345-361
Published Date: 14 August 2017
Diabetes and dyslipidemia: characterizing lipoprotein metabolism
Tomkin GH, Owens D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:333-343
Published Date: 28 July 2017
Emerging use of combination therapies for the management of type 2 diabetes – focus on saxagliptin and dapagliflozin
Yu H, Woo VC
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:317-332
Published Date: 21 July 2017
The role of endoscopic therapy in obesity management: intragastric balloons and aspiration therapy
Kumar N, Sullivan S, Thompson CC
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:311-316
Published Date: 6 July 2017
Dose-ranging pilot randomized trial of amino acid mixture combined with physical activity promotion for reducing abdominal fat in overweight adults
Sasai H, Ueda K, Tsujimoto T, Kobayashi H, Sanbongi C, Ikegami S, Nakata Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:297-309
Published Date: 6 July 2017
Prevalence of diabetes and obesity in association with prematurity and growth restriction
Kopec G, Shekhawat PS, Mhanna MJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:285-295
Published Date: 6 July 2017
Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus
Lau IT, Lee KF, So WY, Tan K, Yeung VTF
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:273-284
Published Date: 30 June 2017
Dyslipidemia and associated factors among diabetic patients attending Durame General Hospital in Southern Nations, Nationalities, and People’s Region
Bekele S, Yohannes T, Mohammed AE
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:265-271
Published Date: 22 June 2017
Diabetes in sub-Saharan Africa – from policy to practice to progress: targeting the existing gaps for future care for diabetes
Pastakia SD, Pekny CR, Manyara SM, Fischer L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:247-263
Published Date: 22 June 2017
Effects of a tailored lifestyle self-management intervention (TALENT) study on weight reduction: a randomized controlled trial
Melchart D, Löw P, Wühr E, Kehl V, Weidenhammer W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:235-245
Published Date: 19 June 2017
Off-label drugs for weight management
Hendricks EJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:223-234
Published Date: 10 June 2017
Sitagliptin ameliorates oxidative stress in experimental diabetic nephropathy by diminishing the miR-200a/Keap-1/Nrf2 antioxidant pathway
Civantos E, Bosch E, Ramirez E, Zhenyukh O, Egido J, Lorenzo O, Mas S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:207-222
Published Date: 7 June 2017
Personalized multistep cognitive behavioral therapy for obesity
Dalle Grave R, Sartirana M, El Ghoch M, Calugi S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:195-206
Published Date: 1 June 2017
Changes in muscle strength after diet-induced weight reduction in adult men with obesity: a prospective study
Kim B, Tsujimoto T, So R, Zhao X, Oh S, Tanaka K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:187-194
Published Date: 9 May 2017
Antibodies against glutamic acid decarboxylase and indices of insulin resistance and insulin secretion in nondiabetic adults: a cross-sectional study
Mendivil CO, Toloza FJK, Ricardo-Silgado ML, Morales-Álvarez MC, Mantilla-Rivas JO, Pinzón-Cortés JA, Lemus HN
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:179-185
Published Date: 8 May 2017
Effect of vitamin K supplementation on insulin sensitivity: a meta-analysis
Suksomboon N, Poolsup N, Darli Ko Ko H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:169-177
Published Date: 2 May 2017
Role of sodium glucose cotransporter-2 inhibitors in type I diabetes mellitus
Ahmadieh H, Ghazal N, Azar ST
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:161-167
Published Date: 2 May 2017
Hearing thresholds in adult Nigerians with diabetes mellitus: a case–control study
Nwosu JN, Chime EN
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:155-160
Published Date: 2 May 2017
Do we need to measure vitamin B12 and magnesium in morbidly obese patients with type 2 diabetes mellitus?
Wåhlén A, Haenni A, Johansson HE
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:151-154
Published Date: 2 May 2017
Glucose-lowering therapies, adequacy of metabolic control, and their relationship with comorbid depression in outpatients with type 2 diabetes in a tertiary hospital in Kenya
Otieno CFF, Kanu JE, Karari EM, Okech-Helu V, Joshi MD, Mutai K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:141-149
Published Date: 28 April 2017
Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research
Levin PA, Nguyen H, Wittbrodt ET, Kim SC
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:123-139
Published Date: 4 April 2017
Comparative effectiveness of glycemic control in patients with type 2 diabetes treated with GLP-1 receptor agonists: a network meta-analysis of placebo-controlled and active-comparator trials
Orme ME, Nguyen H, Lu JY, Thomas SA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:111-122
Published Date: 29 March 2017
Early-life chemical exposures and risk of metabolic syndrome
De Long NE, Holloway AC
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:101-109
Published Date: 21 March 2017
The association of weight loss with patient experience and outcomes in a population of patients with type 2 diabetes mellitus prescribed canagliflozin
Gerlanc NM, Cai J, Tkacz J, Bolge SC, Brady BL
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:89-99
Published Date: 20 March 2017
Long-term management of type 2 diabetes with glucagon-like peptide-1 receptor agonists
Courtney H, Nayar R, Rajeswaran C, Jandhyala R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:79-87
Published Date: 13 March 2017
Single-donor islet transplantation in type 1 diabetes: patient selection and special considerations
Tatum JA, Meneveau MO, Brayman KL
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:73-78
Published Date: 28 February 2017
Clinical utility of metabolic syndrome severity scores: considerations for practitioners
DeBoer MD, Gurka MJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:65-72
Published Date: 20 February 2017
Association between obesity and heart rate variability indices: an intuition toward cardiac autonomic alteration – a risk of CVD
Yadav RL, Yadav PK, Yadav LK, Agrawal K, Sah SK, Islam MN
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:57-64
Published Date: 17 February 2017
Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome
Davies MJ, Merton KW, Vijapurkar U, Balis DA, Desai M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:47-55
Published Date: 27 January 2017
Different consecutive training protocols to design an intervention program for overweight youth: a controlled study
Fiorilli G, Iuliano E, Aquino G, Campanella E, Tsopani D, Di Costanzo A, Calcagno G, di Cagno A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:37-45
Published Date: 16 January 2017
The effects of exercise training and caloric restriction on the cardiac oxytocin natriuretic peptide system in the diabetic mouse
Broderick TL, Jankowski M, Gutkowska J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:27-36
Published Date: 11 January 2017
Improvement of impaired diastolic left ventricular function after diet-induced weight reduction in severe obesity
Karimian S, Stein J, Bauer B, Teupe C
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:19-25
Published Date: 7 January 2017
Role of glycemic control on hospital-related outcomes in patients with diabetes mellitus undergoing renal transplantation
Lamos EM, Wijesinha MA, Ramhamdani S, Magder LS, Silver KD
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:13-17
Published Date: 5 January 2017
Coaching and barriers to weight loss: an integrative review
Muñoz Obino KF, Aguiar Pereira C, Caron-Lienert RS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:1-11
Published Date: 23 December 2016
Acarbose promotes remission of both early and late dumping syndromes in post-bariatric patients
Cadegiani FA, Silva OS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:443-446
Published Date: 7 December 2016
rDNA insulin glargine U300 – a critical appraisal
Wang F, Zassman S, Goldberg PA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:425-441
Published Date: 2 December 2016
Evaluation of serum ferritin and some metal elements in type 2 diabetes mellitus patients: comparative cross-sectional study
Wolide AD, Zawdie B, Alemayehu T, Tadesse S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:417-424
Published Date: 2 December 2016
Symptom profiles of subsyndromal depression in disease clusters of diabetes, excess weight, and progressive cerebrovascular conditions: a promising new type of finding from a reliable innovation to estimate exhaustively specified multiple indicators–multiple causes (MIMIC) models
Francoeur RB
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:391-416
Published Date: 8 December 2016
eHealth technologies to support nutrition and physical activity behaviors in diabetes self-management
Rollo ME, Aguiar EJ, Williams RL, Wynne K, Kriss M, Callister R, Collins CE
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:381-390
Published Date: 4 November 2016
Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015
Higgins V, Piercy J, Roughley A, Milligan G, Leith A, Siddall J, Benford M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:371-380
Published Date: 1 November 2016
Practical combination therapy based on pathophysiology of type 2 diabetes
Levin PA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:355-369
Published Date: 31 October 2016
Teneligliptin real-world efficacy assessment of type 2 diabetes mellitus patients in India (TREAT-INDIA study)
Ghosh S, Trivedi S, Sanyal D, Modi KD, Kharb S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:347-353
Published Date: 8 November 2016
Changes in HbA1c, body weight, and systolic blood pressure in type 2 diabetes patients initiating dapagliflozin therapy: a primary care database study
Scheerer MF, Rist R, Proske O, Meng A, Kostev K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:337-345
Published Date: 31 October 2016
Myocutaneous revascularization following graded ischemia in lean and obese mice
Clark RM, Coffman B, McGuire PG, Howdieshell TR
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:325-336
Published Date: 30 September 2016
Exercise portrayal in children’s television programs: analysis of the UK and Irish programming
Scully P, Reid O, Macken AP, Healy M, Saunders J, Leddin D, Cullen W, Dunne CP, O’Gorman CS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:317-324
Published Date: 23 September 2016
Management of pancreatogenic diabetes: challenges and solutions
Makuc J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:311-315
Published Date: 25 August 2016
Role of sleep quality in the metabolic syndrome
Koren D, Dumin M, Gozal D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:281-310
Published Date: 25 August 2016
Prevalence and determinants of metabolic syndrome: a cross-sectional survey of general medical outpatient clinics using National Cholesterol Education Program-Adult Treatment Panel III criteria in Botswana
Omech B, Tshikuka JG, Mwita JC, Tsima B, Nkomazana O, Amone-P'Olak K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:273-279
Published Date: 30 August 2016
Natural dipeptidyl peptidase-IV inhibitor mangiferin mitigates diabetes- and metabolic syndrome-induced changes in experimental rats
Suman RK, Mohanty IR, Maheshwari U, Borde MK, Deshmukh YA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:261-272
Published Date: 29 August 2016
Teneligliptin in management of type 2 diabetes mellitus
Sharma SK, Panneerselvam A, Singh KP, Parmar G, Gadge P, Swami OC
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:251-260
Published Date: 16 August 2016
Comparison of efficacy and safety of two starting insulin regimens in non-Asian, Asian Indian, and East Asian patients with type 2 diabetes: a post hoc analysis of the PARADIGM study
Ji L, Min KW, Oliveira J, Lew T, Duan R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:243-249
Published Date: 9 August 2016
Incremental increases in economic burden parallels cardiometabolic risk factors in the US
McQueen RB, Ghushchyan V, Olufade T, Sheehan JJ, Nair KV, Saseen JJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:233-241
Published Date: 2 August 2016
Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study
Hassoun AAK, Pathan MF, Medlej RC, Alarouj M, Shaltout I, Chawla MS, Knap D, Vaz JA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:225-232
Published Date: 26 July 2016
Real-world glycemic outcomes in patients with type 2 diabetes initiating exenatide once weekly and liraglutide once daily: a retrospective cohort study
Saunders WB, Nguyen H, Kalsekar I
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:217-223
Published Date: 15 July 2016
Smartphone applications to aid weight loss and management: current perspectives
Sutton EF, Redman LM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:213-216
Published Date: 18 July 2016
The relationship between the presence of lower urinary tract symptoms and waist circumference
Oliveira MC, Varella LR, Angelo PH, Micussi MT
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:207-211
Published Date: 11 July 2016
Adherence to GLP-1 receptor agonist therapy administered by once-daily or once-weekly injection in patients with type 2 diabetes in Germany
Qiao Q, Ouwens MJNM, Grandy S, Johnsson K, Kostev K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:201-205
Published Date: 28 June 2016
Fatty acid desaturase 1 knockout mice are lean with improved glycemic control and decreased development of atheromatous plaque
Powell DR, Gay JP, Smith M, Wilganowski N, Harris A, Holland A, Reyes M, Kirkham L, Kirkpatrick LL, Zambrowicz B, Hansen G, Platt KA, van Sligtenhorst I, Ding ZM, Desai U
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:185-199
Published Date: 22 June 2016
Assessing the incremental benefit of an extended duration lifestyle intervention for the components of the metabolic syndrome
Walden P, Jiang Q, Jackson EA, Oral EA, Weintraub MS, Rubenfire M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:177-184
Published Date: 1 June 2016
A qualitative study of perceptions of determinants of disease burden among young patients with type 1 diabetes and their parents in South India
Verloo H, Meenakumari M, Abraham EJ, Malarvizhi G
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:169-176
Published Date: 19 May 2016
An indirect comparison of HbA1c treatment effect with albiglutide and exenatide 2.0 mg QW using the Bucher method
Martin AA, Parks D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:163-168
Published Date: 19 May 2016
Depression in diabetic patients attending University of Gondar Hospital Diabetic Clinic, Northwest Ethiopia
Birhanu AM, Alemu FM, Ashenafie TD, Balcha SA, Dachew BA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:155-162
Published Date: 11 May 2016
Sources and implications of NADH/NAD+ redox imbalance in diabetes and its complications
Wu J, Jin Z, Zheng H, Yan LJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:145-153
Published Date: 10 May 2016
Metabolic syndrome and C-reactive protein in bank employees
Cattafesta M, Bissoli NS, Salaroli LB
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:137-144
Published Date: 10 May 2016
Advances in the treatment of type 2 diabetes: impact of dulaglutide
Thompson AM, Trujillo JM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:125-136
Published Date: 4 May 2016
Level of control among patients with type 2 diabetes mellitus attending diabetic clinic under family medicine compared to diabetic clinic under endocrinology
AlHabdan MA, AlAteeq MA, AlJurbou FI
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:119-124
Published Date: 18 April 2016
Prescription omega-3 fatty acid products: considerations for patients with diabetes mellitus
Tajuddin N, Shaikh A, Hassan A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:109-118
Published Date: 19 April 2016
Lifestyle Intervention for Weight Loss: a group-based program for Emiratis in Ajman, United Arab Emirates
Sadiya A, Abdi S, Abusnana S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:101-108
Published Date: 18 March 2016
Hematological indices and their correlation with fasting blood glucose level and anthropometric measurements in type 2 diabetes mellitus patients in Gondar, Northwest Ethiopia
Biadgo B, Melku M, Abebe SM, Abebe M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:91-99
Published Date: 17 March 2016
Childhood obesity: prevention is better than cure
Pandita A, Sharma D, Pandita D, Pawar S, Tariq M, Kaul A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:83-89
Published Date: 15 March 2016
Sodium–glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin–metformin
Schwartz SS, Katz A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:71-82
Published Date: 15 March 2016
Genistein treatment increases bone mass in obese, hyperglycemic mice
Michelin RM, Al-Nakkash L, Broderick TL, Plochocki JH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:63-70
Published Date: 15 March 2016
Effects of long-term exercise training on adipose tissue expression of fractalkine and MCP-1 in patients with type 2 diabetes and stable coronary artery disease: a substudy of a randomized controlled trial
Njerve IU, Byrkjeland R, Arnesen H, Åkra S, Solheim S, Seljeflot I
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:55-62
Published Date: 14 March 2016
Metabolic syndrome and associated factors among outpatients of Jimma University Teaching Hospital
Abda E, Hamza L, Tessema F, Cheneke W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:47-53
Published Date: 4 March 2016
Long-term weight loss maintenance for obesity: a multidisciplinary approach
Montesi L, El Ghoch M, Brodosi L, Calugi S, Marchesini G, Dalle Grave R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:37-46
Published Date: 26 February 2016
Patient considerations in type 2 diabetes – role of combination dapagliflozin–metformin XR
Kuecker CM, Vivian EM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:25-35
Published Date: 23 February 2016
Fracture risk in patients with type 2 diabetes under different antidiabetic treatment regimens: a retrospective database analysis in primary care
Pscherer S, Kostev K, Dippel FW, Rathmann W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:17-23
Published Date: 19 February 2016
Assessment of vitamin D levels in newly diagnosed children with type 1 diabetes mellitus comparing two methods of measurement: a facility's experience in the Middle Eastern country of Bahrain
Al-Haddad FA, Rajab MH, Al-Qallaf SM, Musaiger AO, Hart KH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:11-16
Published Date: 25 January 2016
A local renal renin–angiotensin system activation via renal uptake of prorenin and angiotensinogen in diabetic rats
Tojo A, Kinugasa S, Fujita T, Wilcox CS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:1-10
Published Date: 18 January 2016
Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant
Cebeci Z, Kir N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:555-566
Published Date: 16 November 2015
SGLT2 inhibitors – an insulin-independent therapeutic approach for treatment of type 2 diabetes: focus on canagliflozin
Seufert J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:543-554
Published Date: 9 November 2015
Relationship between chronic complications, hypertension, and health-related quality of life in Portuguese patients with type 2 diabetes
Sepúlveda E, Poínhos R, Constante M, Pais-Ribeiro J, Freitas P, Carvalho D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:535-542
Published Date: 30 October 2015
Red cell distribution width in type 2 diabetic patients
Nada AM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:525-533
Published Date: 30 October 2015
Specific cut-off points for waist circumference and waist-to-height ratio as predictors of cardiometabolic risk in Black subjects: a cross-sectional study in Benin and Haiti
EL Mabchour A, Delisle H, Vilgrain C, Larco P, Sodjinou R, Batal M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:513-523
Published Date: 23 October 2015
Emerging utility of once-weekly exenatide in patients with type 2 diabetes
Goud A, Zhong J, Rajagopalan S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:505-512
Published Date: 21 October 2015
Weight loss for women with and without polycystic ovary syndrome following a very low-calorie diet in a community-based setting with trained facilitators for 12 weeks
Nikokavoura EA, Johnston KL, Broom J, Wrieden WL, Rolland C
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:495-503
Published Date: 14 October 2015
Long-term safety and efficacy of insulin degludec in the management of type 2 diabetes
Thuillier P, Alavi Z, Kerlan V
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:483-493
Published Date: 1 October 2015
The clinical utility of aflibercept for diabetic macular edema
Stewart MW
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:473-482
Published Date: 18 September 2015
Bariatric surgery outcomes: a single-center study in the United Arab Emirates
Abusnana S, Abdi S, Tagure B, Elbagir M, Maleckas A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:461-471
Published Date: 18 September 2015
Causes and consequences of obesity: epigenetics or hypokinesis?
Graham MR, Baker JS, Davies B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:455-460
Published Date: 16 September 2015
An exploratory retrospective assessment of a quantitative measure of diabetes risk: medical management and patient impact in a primary care setting
Courtney MR, Moler EJ, Osborne JA, Whitney G, Conard SE
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:447-453
Published Date: 18 September 2015
Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine
Ogedengbe OS, Ezeani IU, Chukwuonye II, Anyabolu EN, Ozor II, Eregie A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:437-445
Published Date: 15 September 2015
C-reactive protein is associated with low-density lipoprotein cholesterol and obesity in type 2 diabetic Sudanese
Dongway AC, Faggad AS, Zaki HY, Abdalla BE
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:427-435
Published Date: 4 September 2015
Current perspectives on the health risks associated with the consumption of advanced glycation end products: recommendations for dietary management
Palimeri S, Palioura E, Diamanti-Kandarakis E
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:415-426
Published Date: 1 September 2015
Evaluation of the relationship between the pelvic floor muscles and insulin resistance
Micussi MT, Freitas RP, Angelo PH, Soares EM, Lemos TM, Maranhão TM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:409-413
Published Date: 28 August 2015
Kinin B1 and B2 receptor deficiency protects against obesity induced by a high-fat diet and improves glucose tolerance in mice
Morais RL, Silva ED, Sales VM, Filippelli-Silva R, Mori MA, Bader M, Pesquero JB
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:399-407
Published Date: 26 August 2015
Lixisenatide accelerates restoration of normoglycemia and improves human beta-cell function and survival in diabetic immunodeficient NOD–scid IL-2rgnull RIP-DTR mice engrafted with human islets
Yang C, Loehn M, Jurczyk A, Przewozniak N, Leehy L, Herrera PL, Shultz LD, Greiner DL, Harlan DM, Bortell R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:387-398
Published Date: 20 August 2015
A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide
Gurung T, Shyangdan DS, O’Hare JP, Waugh N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:363-386
Published Date: 10 August 2015
Metabolic abnormalities in pituitary adenoma patients: a novel therapeutic target and prognostic factor
Zheng X, Li S, Zhang WH, Yang H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:357-361
Published Date: 5 August 2015
Immunization of AGE-modified albumin inhibits diabetic nephropathy progression in diabetic mice
Mashitah MW, Azizah N, Samsu N, Indra MR, Bilal M, Yunisa MV, Arisanti AD
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:347-355
Published Date: 4 August 2015
Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus
Omoto S, Taniura T, Nishizawa T, Tamaki T, Shouzu A,Nomura S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:339-345
Published Date: 27 July 2015
The humanistic and economic burden associated with increasing body mass index in the EU5
Gupta S, Richard L, Forsythe A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:327-338
Published Date: 22 July 2015
Type 2 diabetes mellitus development programs in the new regulatory environment with cardiovascular safety requirements
Yang F, Stewart M, Ye J, DeMets D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:315-325
Published Date: 20 July 2015
Potential glycemic overtreatment in patients ≥75 years with type 2 diabetes mellitus and renal disease: experience from the observational OREDIA study
Penfornis A, Fiquet B, Blicklé JF, Dejager S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:303-313
Published Date: 3 July 2015
Epigenetic and developmental influences on the risk of obesity, diabetes, and metabolic syndrome
Smith CJ, Ryckman KK
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:295-302
Published Date: 29 June 2015
Fixed-dose combinations in type 2 diabetes – role of the canagliflozin metformin combination
Fleming JW, Fleming LW, Davis CS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:287-294
Published Date: 25 June 2015
Randomized, double-blind, placebo-controlled, clinical study on the effect of Diabetinol® on glycemic control of subjects with impaired fasting glucose
Evans M, Judy WV, Wilson D, Rumberger JA, Guthrie N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:275-286
Published Date: 25 June 2015
Interventions to improve long-term weight loss in patients following bariatric surgery: challenges and solutions
McGrice M, Don Paul K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:263-274
Published Date: 23 June 2015
Assessing the obese diabetic patient for bariatric surgery: which candidate do I choose?
Raffaelli M, Sessa L, Mingrone G, Bellantone R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:255-262
Published Date: 8 June 2015
Safety and tolerability of exenatide once weekly in patients with type 2 diabetes: an integrated analysis of 4,328 patients
MacConell L, Gurney K, Malloy J, Zhou M, Kolterman O
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:241-253
Published Date: 18 May 2015
Interaction between leucine and phosphodiesterase 5 inhibition in modulating insulin sensitivity and lipid metabolism
Fu L, Li F, Bruckbauer A, Cao Q, Cui X, Wu R, Shi H, Xue B, Zemel MB
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:227-239
Published Date: 6 May 2015
Health-related quality of life in type 1 and type 2 diabetic patients in a Portuguese central public hospital
Sepúlveda E, Poínhos R, Constante M, Pais-Ribeiro J, Freitas P, Carvalho D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:219-226
Published Date: 29 April 2015
Development of non-alcoholic fatty liver disease scoring system among adult medical check-up patients: a large cross-sectional and prospective validation study
Lesmana CRA, Pakasi LS, Inggriani S, Aidawati ML, Lesmana LA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:213-218
Published Date: 23 April 2015
Fasting during Ramadan: efficacy, safety, and patient acceptability of vildagliptin in diabetic patients
Aziz KMA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:207-211
Published Date: 16 April 2015
Diabetes mellitus and risk factors in human immunodeficiency virus-infected individuals at Jimma University Specialized Hospital, Southwest Ethiopia
Mohammed AE, Shenkute TY, Gebisa WC
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:197-206
Published Date: 15 April 2015
Saroglitazar for the treatment of hypertriglyceridemia in patients with type 2 diabetes: current evidence
Sosale A, Saboo B, Sosale B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:189-196
Published Date: 15 April 2015
Streptozotocin-induced type 1 diabetes in rodents as a model for studying mitochondrial mechanisms of diabetic β cell glucotoxicity
Wu J, Yan LJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:181-188
Published Date: 2 April 2015
Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients with diabetes: results of the POWER survey
Petrella RJ, Gill DP, Berrou JP
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:173-180
Published Date: 24 March 2015
Anagliptin in the treatment of type 2 diabetes: safety, efficacy, and patient acceptability
Nishio S, Abe M, Ito H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:163-171
Published Date: 18 March 2015
Factors affecting high-sensitivity cardiac troponin T elevation in Japanese metabolic syndrome patients
Hitsumoto T, Shirai K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:157-162
Published Date: 10 March 2015
Daily intake of rosehip extract decreases abdominal visceral fat in preobese subjects: a randomized, double-blind, placebo-controlled clinical trial
Nagatomo A, Nishida N, Fukuhara I, Noro A, Kozai Y, Sato H, Matsuura Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:147-156
Published Date: 6 March 2015
Withdrawal of sulfonylureas from patients with type 2 diabetes receiving long-term sulfonylurea and insulin combination therapy results in deterioration of glycemic control: a randomized controlled trial
Srivanichakorn W, Sriwijitkamol A, Kongchoo A, Sriussadaporn S, Plengvidhya N, Lertwattanarak R, Vannasaeng S, Thongtang N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:137-145
Published Date: 2 March 2015
Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management
Nitzan O, Elias M, Chazan B, Saliba W,
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:129-136
Published Date: 26 February 2015
Sotagliflozin improves glycemic control in nonobese diabetes-prone mice with type 1 diabetes
Powell DR, Doree D, Jeter-Jones S, Ding ZM, Zambrowicz B, Sands A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:121-127
Published Date: 26 February 2015
Effect of different exercise intensities on the pancreas of animals with metabolic syndrome
Amaral F, Lima NEA, Ornelas E, Simardi L, Fonseca FLA, Maifrino LBM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:115-120
Published Date: 13 February 2015
Angiotensin receptor blocker telmisartan suppresses renal gluconeogenesis during starvation
Tojo A, Hatakeyama S, Kinugasa S, Nangaku M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:103-113
Published Date: 13 February 2015
Sexual dysfunction in diabetic women: prevalence and differences in type 1 and type 2 diabetes mellitus
Mazzilli R, Imbrogno N, Elia J, Delfino M, Bitterman O, Napoli A, Mazzilli F
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:97-101
Published Date: 11 February 2015
Clinical role of a fixed combination of standardized Berberis aristata and Silybum marianum extracts in diabetic and hypercholesterolemic patients intolerant to statins
Di Pierro F, Bellone I, Rapacioli G, Putignano P
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:89-96
Published Date: 4 February 2015
GABAergic system in the endocrine pancreas: a new target for diabetes treatment
Wan Y, Wang Q, Prud’homme GJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:79-87
Published Date: 3 February 2015
The prevalence of adverse cardiometabolic responses to exercise training with evidence-based practice is low
Dalleck LC, Van Guilder GP, Richardson TB, Vella CA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:73-78
Published Date: 29 January 2015
Level of sustained glycemic control and associated factors among patients with diabetes mellitus in Ethiopia: a hospital-based cross-sectional study
Abebe SM, Berhane Y, Worku A, Alemu S, Mesfin N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:65-71
Published Date: 27 January 2015
Glycosylated hemoglobin as a screening test for hyperglycemia in antipsychotic-treated patients: a follow-up study
Steylen PMJ, van der Heijden FMMA, Hoogendijk WJG, Verhoeven WMA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:57-63
Published Date: 23 January 2015
Recognition of and steps to mitigate anxiety and fear of pain in injectable diabetes treatment
Kruger DF, LaRue S, Estepa P
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:49-56
Published Date: 16 January 2015
Glycemic control after initiating basal insulin therapy in patients with type 2 diabetes: a primary care database analysis
Kostev K, Dippel FW, Rathmann W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:45-48
Published Date: 14 January 2015
Psychosocial interventions for the diabetic patient
Harvey JN
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:29-43
Published Date: 9 January 2015
Type 2 diabetes in Brazil: epidemiology and management
Almeida-Pititto B, Dias ML, Moraes ACF, Ferreira SRG, Franco DR, Eliaschewitz FG
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:17-28
Published Date: 5 January 2015
Salivary glucose concentration exhibits threshold kinetics in normal-weight, overweight, and obese children
Hartman ML, Goodson JM, Barake R, Alsmadi O, Al-Mutawa S, Ariga J, Soparkar P, Behbehani J, Behbehani K, Welty F
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:9-15
Published Date: 17 December 2014
Health outcomes in diabetics measured with Minnesota Community Measurement quality metrics
Takahashi PY, St Sauver JL, Finney Rutten LJ, Jacobson RM, Jacobson DJ, McGree ME, Ebbert JO
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:1-8
Published Date: 16 December 2014
Mechanism linking diabetes mellitus and obesity
Al-Goblan AS, Al-Alfi MA, Khan MZ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:587-591
Published Date: 4 December 2014
Genetic and epigenetic catalysts in early-life programming of adult cardiometabolic disorders
Estampador AC, Franks PW
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:575-586
Published Date: 1 December 2014
Management of adult diabetic ketoacidosis
Rosival V
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:571-573
Published Date: 28 November 2014
Evaluation of the indications and arrhythmic patterns of 24 hour Holter electrocardiography among hypertensive and diabetic patients seen at OAUTHC, Ile-Ife Nigeria
Adebayo RA, Ikwu AN, Balogun MO, Akintomide AO, Mene-Afejuku TO, Adeyeye VO, Bamikole OJ, Bisiriyu LA, Ajayi OE, Ogunyemi SA, Oketona OA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:565-570
Published Date: 26 November 2014
Palmitoleic acid reduces intramuscular lipid and restores insulin sensitivity in obese sheep
Duckett SK, Volpi-Lagreca G, Alende M, Long NM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:553-563
Published Date: 20 November 2014
Myocardial perfusion imaging for evaluation of suspected ischemia and its relationship with glycemic control in South African subjects with diabetes mellitus
Shmendi A, Pirie F, Naidoo DP, Tlou B, Pilloy W, Motala AA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:545-552
Published Date: 14 November 2014
Integrated bariatric surgery residency
Eltorai AE
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:543-544
Published Date: 13 November 2014
Variability in Zucker diabetic fatty rats: differences in disease progression in hyperglycemic and normoglycemic animals
Wang X, DuBois DC, Sukumaran S, Ayyar V, Jusko WJ, Almon RR
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:531-541
Published Date: 11 November 2014
Independent and combined effect of diet and exercise in adults with prediabetes
Sénéchal M, Slaght J, Bharti N, Bouchard DR
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:521-529
Published Date: 31 October 2014
Relationship between oxidized low-density lipoprotein antibodies and obesity in different glycemic situations
Babakr AT, Elsheikh OM, Almarzouki AA, Assiri AM, Abdalla BE, Zaki HY, Fatani SH, NourEldin EM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:513-520
Published Date: 24 October 2014
Prevalence of cardiometabolic risk factors and metabolic syndrome in obese Kuwaiti adolescents
Boodai SA, Cherry LM, Sattar NA, Reilly JJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:505-511
Published Date: 24 October 2014
Expression of gluconeogenic enzymes and 11β-hydroxysteroid dehydrogenase type 1 in liver of diabetic mice after acute exercise
Brust KB, Corbell KA, Al-Nakkash L, Babu JR, Broderick TL
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:495-504
Published Date: 21 October 2014
Significance of HbA1c and its measurement in the diagnosis of diabetes mellitus: US experience
Juarez DT, Demaris KM, Goo R, Mnatzaganian CL, Wong Smith H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:487-494
Published Date: 20 October 2014
Testosterone levels and type 2 diabetes in men: current knowledge and clinical implications
Beatrice AM, Dutta D, Kumar M, Shivaprasad KS, Sinha A, Ray S, Chowdhury S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:481-486
Published Date: 20 October 2014
Using the health action process approach to predict and improve health outcomes in individuals with type 2 diabetes mellitus
MacPhail M, Mullan B, Sharpe L, MacCann C, Todd J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:469-479
Published Date: 16 October 2014
Randomized, double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects [Retraction]
Vinson JA, Burnham BR, Nagendran MV
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:467-468
Published Date: 16 October 2014
Estimating the prevalence of comorbid conditions and their effect on health care costs in patients with diabetes mellitus in Switzerland
Huber CA, Diem P, Schwenkglenks M, Rapold R, Reich O
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:455-465
Published Date: 1 October 2014
Effect of BMI on cardiovascular and metabolic syndrome risk factors in an Appalachian pediatric population
Weber KE, Fischl AFR, Murray PJ, Conway BN
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:445-453
Published Date: 25 September 2014
The effect of a lifestyle intervention on metabolic health in young women
Dunn SL, Siu W, Freund J, Boutcher SH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:437-444
Published Date: 19 September 2014
Relationship between chronic kidney disease and metabolic syndrome: current perspectives
Nashar K, Egan BM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:421-435
Published Date: 18 September 2014
Sex differences in type 2 diabetes: focus on disease course and outcomes
Arnetz L, Ekberg NR, Alvarsson M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:409-420
Published Date: 16 September 2014
Effect of rosuvastatin on diabetic polyneuropathy: a randomized, double-blind, placebo-controlled Phase IIa study
Hernández-Ojeda J, Román-Pintos LM, Rodríguez-Carrízalez AD, Troyo-Sanromán R, Cardona-Muñoz EG, Alatorre-Carranza MP, Miranda-Díaz AG
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:401-407
Published Date: 4 September 2014
Treating the elderly diabetic patient: special considerations
Kezerle L, Shalev L, Barski L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:391-400
Published Date: 28 August 2014
Diabetes disease progression in Goto-Kakizaki rats: effects of salsalate treatment
Wang X, DuBois DC, Cao Y, Jusko WJ, Almon RR
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:381-389
Published Date: 1 August 2014
A community-based exercise intervention transitions metabolically abnormal obese adults to a metabolically healthy obese phenotype
Dalleck LC, Van Guilder GP, Richardson TB, Bredle DL, Janot JM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:369-380
Published Date: 1 August 2014
Is adherence a relevant issue in the self-management education of diabetes? A mixed narrative review
Debussche X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:357-367
Published Date: 29 July 2014
Elevated body mass index as a risk factor for chronic kidney disease: current perspectives
Garland JS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:347-355
Published Date: 29 July 2014
Prevalence of metabolic syndrome and its components based on a harmonious definition among adults in Morocco
El Brini O, Akhouayri O, Gamal A, Mesfioui A, Benazzouz B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:341-346
Published Date: 31 July 2014
Linking obesity with type 2 diabetes: the role of T-bet
Wali JA, Thomas HE, Sutherland APR
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:331-340
Published Date: 22 July 2014
Decreased basal chloride secretion and altered cystic fibrosis transmembrane conductance regulatory protein, Villin, GLUT5 protein expression in jejunum from leptin-deficient mice
Leung L, Kang J, Rayyan E, Bhakta A, Barrett B, Larsen D, Jelinek R, Willey J, Cochran S, Broderick TL, Al-Nakkash L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:321-330
Published Date: 21 July 2014
Pioglitazone improves the cardio-ankle vascular index in patients with type 2 diabetes mellitus treated with metformin
Ohira M, Yamaguchi T, Saiki A, Ban N, Kawana H, Nagumo A, Murano T, Shirai K, Tatsuno I
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:313-319
Published Date: 17 July 2014
The effect of vagal nerve blockade using electrical impulses on glucose metabolism in nondiabetic subjects
Sathananthan M, Ikramuddin S, Swain JM, Shah M, Piccinini F, Dalla Man C, Cobelli C, Rizza RA, Camilleri M, Vella A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:305-312
Published Date: 11 July 2014
Relationship between insulin resistance and plasma vitamin D in adults
Badawi A, Sayegh S, Sadoun E, Al-Thani M, Arora P, Haddad PS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:297-303
Published Date: 7 July 2014
Abdominal obesity: causal factor or simply a symptom of obesity-related health risk
Oh S, Tanaka K, Noh JW, So R, Tsujimoto T, Sasai H, Kim M, Shoda J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:289-296
Published Date: 3 July 2014
Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
Holland DQ, Neumiller JJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:277-288
Published Date: 3 July 2014
Combination of the sodium-glucose cotransporter-2 inhibitor empagliflozin with orlistat or sibutramine further improves the body-weight reduction and glucose homeostasis of obese rats fed a cafeteria diet
Vickers SP, Cheetham SC, Headland KR, Dickinson K, Grempler R, Mayoux E, Mark M, Klein T
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:265-275
Published Date: 1 July 2014
Management of adult diabetic ketoacidosis
Gosmanov AR, Gosmanova EO, Dillard-Cannon E
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:255-264
Published Date: 30 June 2014
AMPK activation: a therapeutic target for type 2 diabetes?
Coughlan KA, Valentine RJ, Ruderman NB, Saha AK
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:241-253
Published Date: 24 June 2014
Exenatide extended-release: a once weekly treatment for patients with type 2 diabetes
Mann KV, Raskin P
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:229-239
Published Date: 24 June 2014
Is insulin degludec a more effective treatment for patients using high doses of insulin glargine but not attaining euglycemia? Some case reports from India
Sinha B, Gangopadhyay KK, Ghosal S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:225-228
Published Date: 23 June 2014
Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges
Bruni A, Gala-Lopez B, Pepper AR, Abualhassan NS, Shapiro AM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:211-223
Published Date: 23 June 2014
Metabolic profiling of plasma amino acids shows that histidine increases following the consumption of pork
Samman S, Crossett B, Somers M, Bell KJ, Lai NT, Sullivan DR, Petocz P
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:203-210
Published Date: 19 June 2014
Retrospective study on the efficacy of a low-carbohydrate diet for impaired glucose tolerance
Maekawa S, Kawahara T, Nomura R, Murase T, Ann Y, Oeholm M, Harada M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:195-201
Published Date: 13 June 2014
Regulation of dipeptidyl peptidase 4 production in adipocytes by glucose
Das SS, Hayashi H, Sato T, Yamada R, Hiratsuka M, Hirasawa N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:185-194
Published Date: 24 May 2014
Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus
Lorber D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:169-183
Published Date: 23 May 2014
Holistic approach to prevention and management of type 2 diabetes mellitus in a family setting
Ofori SN, Unachukwu CN
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:159-168
Published Date: 23 May 2014
Prevalence and pattern of overweight and obesity in three rural communities in southwest Nigeria
Adebayo RA, Balogun MO, Adedoyin RA, Obashoro-John OA, Bisiriyu LA, Abiodun OO
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:153-158
Published Date: 10 May 2014
Effects of body mass index-related disorders on cognition: preliminary results
Yesavage JA, Kinoshita LM, Noda A, Lazzeroni LC, Fairchild JK, Taylor J, Kulick D, Friedman L, Cheng J, Zeitzer JM, O'Hara R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:145-151
Published Date: 8 May 2014
Prevalence of diagnosed and undiagnosed diabetes mellitus in adults aged 19 years and older in Basrah, Iraq
Mansour AA, Al-Maliky AA, Kasem B, Jabar A, Mosbeh KA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:139-144
Published Date: 2 May 2014
Egg consumption and cardiovascular disease among diabetic individuals: a systematic review of the literature
Tran NL, Barraj LM, Heilman JM, Scrafford CG
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:121-137
Published Date: 24 March 2014
Comparative effectiveness of liraglutide in the treatment of type 2 diabetes
Rigato M, Fadini GP
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:107-120
Published Date: 18 March 2014
Diabetes and sexual dysfunction: current perspectives
Maiorino MI, Bellastella G, Esposito K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:95-105
Published Date: 6 March 2014
Optimal management of type 2 diabetes in patients with increased risk of hypoglycemia
Anderson M, Powell J, Campbell KM, Taylor JR
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:85-94
Published Date: 6 March 2014
Inhibition of the methionine aminopeptidase 2 enzyme for the treatment of obesity
Joharapurkar AA, Dhanesha NA, Jain MR
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:73-84
Published Date: 28 February 2014
Evidence-based diabetes nutrition therapy recommendations are effective: the key is individualization
Franz MJ, Boucher JL, Evert AB
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:65-72
Published Date: 24 February 2014
Akt/PKB activation and insulin signaling: a novel insulin signaling pathway in the treatment of type 2 diabetes
Mackenzie RWA, Elliott BT
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:55-64
Published Date: 13 February 2014
Partnering with diabetes educators to improve patient outcomes
Burke SD, Sherr D, Lipman RD
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:45-53
Published Date: 12 February 2014
Management of obesity and cardiometabolic risk – role of phentermine/extended release topiramate
Sweeting AN, Tabet E, Caterson ID, Markovic TP
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:35-44
Published Date: 12 February 2014
Stress and the inflammatory process: a major cause of pancreatic cell death in type 2 diabetes
Montane J, Cadavez L, Novials A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:25-34
Published Date: 3 February 2014
Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated
Irons BK, Minze MG
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:15-24
Published Date: 18 January 2014
TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity
Zambad SP, Tuli D, Mathur A, Ghalsasi SA, Chaudhary AR, Deshpande S, Gupta RC, Chauthaiwale V, Dutt C
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:1-14
Published Date: 21 December 2013
Improved function and proliferation of adult human beta cells engrafted in diabetic immunodeficient NOD-scid IL2rγnull mice treated with alogliptin
Jurczyk A, diIorio P, Brostowin D, Leehy L, Yang C, Urano F, Harlan DM, Shultz LD, Greiner DL, Bortell R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:493-499
Published Date: 13 December 2013
HbA1c for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cutoff perform?
Kowall B, Rathmann W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:477-491
Published Date: 29 November 2013
The effects of diet- and diet plus exercise-induced weight loss on basal metabolic rate and acylated ghrelin in grade 1 obese subjects
Lopes AL, Fayh AP, Campos LG, Teixeira BC, Carteri RBK, Ribeiro JL, Friedman R, Reischak-Oliveira A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:469-475
Published Date: 29 November 2013
SGLT-2 inhibitors and their potential in the treatment of diabetes
Rosenwasser RF, Sultan S, Sutton D, Choksi R, Epstein BJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:453-467
Published Date: 27 November 2013
Effects of a recreational physical activity and healthy habits orientation program, using an illustrated diary, on the cardiovascular risk profile of overweight and obese schoolchildren: a pilot study in a public school in Brasilia, Federal District, Brazil
Militão AG, Karnikowski MGO, Silva FR, Militão ESG, Pereira RMS, Campbell CSG
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:445-451
Published Date: 27 November 2013
Comparison of extended release GLP-1 receptor agonist therapy versus sitagliptin in the management of type 2 diabetes
Stolar MW, Grimm M, Chen S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:435-444
Published Date: 22 November 2013
Impact of glucose excursion and mean glucose concentration in oral glucose-tolerance test on oxidative stress among Japanese Americans
Nakanishi S, Yoneda M, Maeda S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:427-433
Published Date: 22 November 2013
Importance of family/social support and impact on adherence to diabetic therapy
Miller TA, DiMatteo MR
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:421-426
Published Date: 6 November 2013
Predicting cardiometabolic risk: waist-to-height ratio or BMI. A meta-analysis
Savva SC, Lamnisos D, Kafatos AG
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:403-419
Published Date: 24 October 2013
The effect of very low-calorie diets on renal and hepatic outcomes: a systematic review
Rolland C, Mavroeidi A, Johnston KL, Broom J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:393-401
Published Date: 11 October 2013
Evaluation of the maximum beyond-use-date stability of regular human insulin extemporaneously prepared in 0.9% sodium chloride in a polyvinyl chloride bag
Rocchio MA, Belisle CD, Greenwood BC, Cotugno MC, Szumita PM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:389-392
Published Date: 11 October 2013
Hepatic function and the cardiometabolic syndrome
Wiernsperger N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:379-388
Published Date: 10 October 2013
Socioeconomic status and obesity in Abia State, South East Nigeria
Chukwuonye II, Chuku A, Okpechi IG, Onyeonoro UU, Madukwe OO, Okafor GOC, Ogah OS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:371-378
Published Date: 16 October 2013
Radiographic evaluation of the effect of obesity on alveolar bone in rats with ligature-induced periodontal disease
do Nascimento CM, Cassol T, da Silva FS, Bonfleur ML, Nassar CA, Nassar PO
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:365-370
Published Date: 7 October 2013
Treatment of type 2 diabetes in chronic kidney disease: a case for linagliptin in the treatment of diabetes in severe renal impairment
Scott D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:359-363
Published Date: 2 October 2013
Systematic review of clinical studies related to pork intake and metabolic syndrome or its components
Stettler N, Murphy MM, Barraj LM, Smith KM, Ahima RS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:347-357
Published Date: 25 September 2013
Metabolic syndrome in hemodialysis patients as a risk factor for new-onset diabetes mellitus after renal transplant: a prospective observational study
Bonet J, Martinez-Castelao A, Bayés B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:339-346
Published Date: 18 September 2013
Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review
Colosia AD, Palencia R, Khan S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:327-338
Published Date: 17 September 2013
Effects of combination therapy with mitiglinide and voglibose on postprandial plasma glucose in patients with type 2 diabetes mellitus
Konya H, Katsuno T, Tsunoda T, Yano Y, Kamitani M, Miuchi M, Hamaguchi T, Miyagawa JI, Namba M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:317-325
Published Date: 2 September 2013
Effects of a leucine and pyridoxine-containing nutraceutical on body weight and composition in obese subjects
Zemel MB, Bruckbauer A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:309-315
Published Date: 23 August 2013
Treatment outcome and prognostic indices in patients with hyperglycemic emergencies
Ezeani IU, Eregie A, Ogedengbe OS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:303-307
Published Date: 19 August 2013
Plasminogen activator inhibitor-1, free fatty acids, and insulin resistance in patients with myocardial infarction
Gruzdeva O, Uchasova E, Dyleva Y, Belik E, Shurygina E, Barbarash O
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:293-301
Published Date: 13 August 2013
Prevalence of abdominal obesity in Abia State, Nigeria: results of a population-based house-to-house survey
Chukwuonye II, Chuku A, Onyeonoro UU, Okpechi IG, Madukwe OO, Umeizudike TI, Ogah OS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:285-291
Published Date: 1 August 2013
Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study
Usharani P, Fatima N, Muralidhar N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:275-284
Published Date: 26 July 2013
Effect of tomato consumption on high-density lipoprotein cholesterol level: a randomized, single-blinded, controlled clinical trial
Cuevas-Ramos D, Almeda-Valdés P, Chávez-Manzanera E, Meza-Arana CE, Brito-Córdova G, Mehta R, Pérez-Méndez O, Gómez-Pérez FJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:263-273
Published Date: 26 July 2013
Effect of calcium channel blockers on incidence of diabetes: a meta-analysis
Noto H, Goto A, Tsujimoto T, Noda M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:257-261
Published Date: 26 July 2013
Potential modification of the UKPDS risk engine and evaluation of macrovascular event rates in controlled clinical trials
Yang F, Ye J, Pomerantz K, Stewart M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:247-256
Published Date: 12 July 2013
Association of FTO and PPARG polymorphisms with obesity in Portuguese women
Ferreira Carlos F, Silva-Nunes J, Flores O, Brito M, Doria G, Veiga L, Baptista PV
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:241-245
Published Date: 11 July 2013
Evidence for the benefit of exercise therapy in patients with type 2 diabetes
Madden KM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:233-239
Published Date: 3 July 2013
Clinical potential of lixisenatide once daily treatment for type 2 diabetes mellitus
Petersen AB, Christensen M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:217-231
Published Date: 17 June 2013
Lorcaserin for weight management
Taylor JR, Dietrich E, Powell J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:209-216
Published Date: 13 June 2013
Management of limited joint mobility in diabetic patients
Abate M, Schiavone C, Salini V, Andia I
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:197-207
Published Date: 7 May 2013
Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes
Kishimoto M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:187-195
Published Date: 6 May 2013
Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries
Ostenson CG, Matthaei S, Reaney M, Krarup T, Guerci B, Kiljanski J, Salaun-Martin C, Sapin H, Bruhn D, Mathieu C, Theodorakis M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:171-185
Published Date: 26 April 2013
Managing diabetic patients with moderate or severe renal impairment using DPP-4 inhibitors: focus on vildagliptin
Russo E, Penno G, Del Prato S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:161-170
Published Date: 24 April 2013
Predictors and prevention of diabetic cardiomyopathy
Chavali V, Tyagi SC, Mishra PK
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:151-160
Published Date: 11 April 2013
An observational study of acarbose treatment in patients with type 2 diabetes from the Middle East and Morocco
Shihabi AR, Moussa EM, Sobierajska H, Schmidt B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:141-150
Published Date: 9 April 2013
Clinical utility of phentermine/topiramate (Qsymia™) combination for the treatment of obesity
Shin JH, Gadde KM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:131-139
Published Date: 8 April 2013
Gender difference in response predictors after 1-year exenatide therapy twice daily in type 2 diabetic patients: a real world experience
Anichini R, Cosimi S, Di Carlo A, Orsini P, De Bellis A, Seghieri G, Franconi F, Baccetti F
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:123-129
Published Date: 8 April 2013
The impact of brief high-intensity exercise on blood glucose levels
Adams OP
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:113-122
Published Date: 27 February 2013
Relationship between free fatty acids, insulin resistance markers, and oxidized lipoproteins in myocardial infarction and acute left ventricular failure
Gruzdeva O, Uchasova E, Dyleva Y, Belik E, Kashtalap V, Barbarash O
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:103-111
Published Date: 18 February 2013
Synergistic effects of metformin, resveratrol, and hydroxymethylbutyrate on insulin sensitivity
Bruckbauer A, Zemel MB
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:93-102
Published Date: 13 February 2013
Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey
Sadosky A, Schaefer C, Mann R, Bergstrom F, Baik R, Parsons B, Nalamachu S, Nieshoff E, Stacey BR, Anschel A, Tuchman M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:79-92
Published Date: 8 February 2013
Guidelines in the management of diabetic nerve pain clinical utility of pregabalin
Vinik AI, Casellini CM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:57-78
Published Date: 22 February 2013
Antihyperglycemic, antihyperlipidemic, anti-inflammatory and adenosine deaminase–lowering effects of garlic in patients with type 2 diabetes mellitus with obesity
Kumar R, Chhatwal S, Arora S, Sharma S, Singh J, Singh N, Bhandari V, Khurana A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:49-56
Published Date: 19 January 2013
Prevalence of overweight and obesity in adult Nigerians – a systematic review
Chukwuonye II, Chuku A, John C, Ohagwu KA, Imoh ME, Isa SE, Ogah OS, Oviasu E
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:43-47
Published Date: 22 January 2013
Exenatide once weekly: sustained improvement in glycemic control and cardiometabolic measures through 3 years
MacConell L, Pencek R, Li Y, Maggs D, Porter L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:31-41
Published Date: 21 January 2013
Collagen-based wound dressings for the treatment of diabetes-related foot ulcers: a systematic review
Holmes C, Wrobel JS, MacEachern MP, Boles BR
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:17-29
Published Date: 17 January 2013
Persistent hypertriglyceridemia in statin-treated patients with type 2 diabetes mellitus
Feher M, Greener M, Munro N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:11-15
Published Date: 10 January 2013
Emerging DPP-4 inhibitors: focus on linagliptin for type 2 diabetes
Gallwitz B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:1-9
Published Date: 4 January 2013
Association of lipid profile and waist circumference as cardiovascular risk factors for overweight and obesity among school children in Qatar
Rizk NM, Yousef M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:425-432
Published Date: 20 December 2012
Increased variability and abnormalities in pancreatic enzyme concentrations in otherwise asymptomatic subjects with type 2 diabetes
Malloy J, Gurney K, Shan K, Yan P, Chen S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:419-424
Published Date: 17 December 2012
Social support in type II diabetes care: a case of too little, too late
Kadirvelu A, Sadasivan S, Ng SH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:407-417
Published Date: 22 November 2012
Frequency of diabetes, impaired fasting glucose, and glucose intolerance in high-risk groups identified by a FINDRISC survey in Puebla City, Mexico
García-Alcalá H, Genestier-Tamborero CN, Hirales-Tamez O, Salinas-Palma J, Soto-Vega E
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:403-406
Published Date: 19 November 2012
Obstructive sleep apnea and bone mineral density in obese patients
Mariani S, Fiore D, Varone L, Basciani S, Persichetti A, Watanabe M, Saponara M, Spera G, Moretti C, Gnessi L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:395-401
Published Date: 7 November 2012
Health-related quality of life, adiposity, and sedentary behavior in patients with early schizophrenia: preliminary study
Strassnig M, Brar JS, Ganguli R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:389-394
Published Date: 26 October 2012
Screening strategies and predictive diagnostic tools for the development of new-onset diabetes mellitus after transplantation: an overview
Pham PT, Edling KL, Chakkera HA, Pham PC, Pham PM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:379-387
Published Date: 26 October 2012
Association of ADIPOQ +45T>G polymorphism with body fat mass and blood levels of soluble adiponectin and inflammation markers in a Mexican-Mestizo population
Guzman-Ornelas MO, Chavarria-Avila E, Munoz-Valle JF, Armas-Ramos LE, Castro-Albarran J, Aguilar Aldrete ME, Oregon-Romero E, Vazquez-Del Mercado M, Navarro-Hernandez RE
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:369-378
Published Date: 17 October 2012
Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations
Rosak C, Mertes G
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:357-367
Published Date: 12 October 2012
The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults
Da Costa LA, Arora P, García-Bailo B, Karmali M, El-Sohemy A, Badawi A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:347-355
Published Date: 4 October 2012
Atherosclerosis and atherosensitivity in two southwest Algerian desert rodents, Psammomys obesus and Gerbillus gerbillus, and in Rattus norvegicus
El-Aoufi S, Lazourgui MA, Griene L, Maouche B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:337-345
Published Date: 18 September 2012
Nutritional therapy for the management of diabetic gastroparesis: clinical review
Sadiya A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:329-335
Published Date: 7 September 2012
Clinical potential of sodium-glucose cotransporter 2 inhibitors in the management of type 2 diabetes
Kim Y, Babu AR
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:313-327
Published Date: 31 August 2012
Impact of physical activity and bodyweight on health-related quality of life in people with type 2 diabetes
Eckert K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:303-311
Published Date: 23 August 2012
Potential role of linagliptin as an oral once-daily treatment for patients with type 2 diabetes
Hoimark L, Laursen T, Rungby J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:295-302
Published Date: 23 August 2012
Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
Al Sifri S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:293-294
Published Date: 15 August 2012
Reduction in urinary albumin excretion with a moderate low-carbohydrate diet in patients with type 2 diabetes: a 12-month intervention
Haimoto H, Sasakabe T, Umegaki H, Wakai K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:283-291
Published Date: 13 August 2012
Microvesicles/exosomes as potential novel biomarkers of metabolic diseases
Müller G
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:247-282
Published Date: 7 August 2012
Six-minute walk test in non-insulin-dependent diabetes mellitus patients living in Northwest Africa
Latiri I, Elbey R, Hcini K, Zaoui A, Charfeddine B, Maarouf MR, Tabka Z, Zbidi A, Ben Saad H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:227-245
Published Date: 7 August 2012
Prediction of insulin resistance with anthropometric measures: lessons from a large adolescent population
Wedin WK, Diaz-Gimenez L, Convit AJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:219-225
Published Date: 23 July 2012
Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control
Di Pierro F, Villanova N, Agostini F, Marzocchi R, Soverini V, Marchesini G
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:213-217
Published Date: 17 July 2012
Right Diet: a television series to combat obesity among adolescents in Kuwait
Al-Haifi AR, Al-Fayez MA, Al-Nashi B, Al-Athari BI, Bawadi H, Musaiger AO
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:205-212
Published Date: 6 July 2012
Insulin degludec as an ultralong-acting basal insulin once a day: a systematic review
Wang F, Surh J, Kaur M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:191-204
Published Date: 5 July 2012
Comparison with ancestral diets suggests dense acellular carbohydrates promote an inflammatory microbiota, and may be the primary dietary cause of leptin resistance and obesity
Spreadbury I
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:175-189
Published Date: 6 July 2012
Glucagon-like peptide-1 receptor agonists as add-on therapy to basal insulin in patients with type 2 diabetes: a systematic review
Berlie H, Hurren KM, Pinelli NR
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:165-174
Published Date: 3 July 2012
Pentosidine levels in nonproteinuric diabetes associated with both low estimated glomerular filtration rate and cataract
Lim XL, Teo BW, Tai BC, Wong TY, Ng DP
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:155-164
Published Date: 29 June 2012
Glucose estimation in the salivary secretion of diabetes mellitus patients
Abikshyeet P, Ramesh V, Oza N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:149-154
Published Date: 12 July 2012
Targeting the kidney and glucose excretion with dapagliflozin: preclinical and clinical evidence for SGLT2 inhibition as a new option for treatment of type 2 diabetes mellitus
Whaley JM, Tirmenstein M, Reilly TP, Poucher SM, Saye J, Parikh S, List JF
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:135-148
Published Date: 23 July 2012
Long-term (52–78 weeks) treatment with colesevelam HCl added to metformin therapy in type 2 diabetes mellitus patients
Bays HE
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:125-134
Published Date: 28 May 2012
Potent antiatherosclerotic effects of alogliptin in addition to its potent antidiabetic effects
Kapoor S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:121-123
Published Date: 11 May 2012
Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
AlMaatouq MA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:109-119
Published Date: 1 May 2012
Clinical features and treatment of maturity onset diabetes of the young (MODY)
Gardner DS,Tai ES
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:101-108
Published Date: 1 May 2012
Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy?
Dincer UD
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:89-99
Published Date: 5 April 2012
Obesity: considerations about etiology, metabolism, and the use of experimental models
Pereira-Lancha LO, Campos-Ferraz PL, Lancha Junior AH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:75-87
Published Date: 10 April 2012
Uncovering undetected hypoglycemic events
Unger J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:57-74
Published Date: 8 March 2012
Negative association of acetate with visceral adipose tissue and insulin levels
Layden BT, Yalamanchi SK, Wolever TMS, Dunaif A, Lowe Jr WL
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:49-55
Published Date: 28 February 2012
Effect of orally administered dipterinyl calcium pentahydrate on oral glucose tolerance in diet-induced obese mice
Nikoulina SE, Fuchs D, Moheno P
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:43-47
Published Date: 24 February 2012
Safety and tolerability of exenatide twice daily in patients with type 2 diabetes: integrated analysis of 5594 patients from 19 placebo-controlled and comparator-controlled clinical trials
MacConell L, Brown C, Gurney K, Han J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:29-41
Published Date: 20 February 2012
Randomized, double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects
Vinson JA, Burnham BR, Nagendran MV
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:21-27
Published Date: 18 January 2012
Insulin detemir for the treatment of obese patients with type 2 diabetes
Hollander PA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:11-19
Published Date: 10 January 2012
Cumulative clinical experience with use of insulin lispro: critical appraisal, role in therapy, and patient considerations
Uy J, Fogelfeld L, Guerra Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:1-10
Published Date: 10 January 2012
Arab Teens Lifestyle Study (ATLS): objectives, design, methodology and implications
Al-Hazzaa HM, Musaiger AO; ATLS Research Group
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:417-426
Published Date: 20 December 2011
Effect of Ramadan fasting on metabolic markers, body composition, and dietary intake in Emiratis of Ajman (UAE) with metabolic syndrome
Sadiya A, Ahmed S, Siddieg HH, Babas IJ, Carlsson M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:409-416
Published Date: 15 December 2011
Association of patient-rated severity with other outcomes in patients with painful diabetic peripheral neuropathy
Taylor-Stokes G, Pike J, Sadosky A, Chandran A, Toelle T
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:401-408
Published Date: 5 December 2011
Comparison of demographic and clinical characteristics influencing health-related quality of life in patients with diabetic foot ulcers and those without foot ulcers
Yekta Z, Pourali R, Ghasemi-rad M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:393-399
Published Date: 2 December 2011
Resistance training associated with the administration of anabolic-androgenic steroids improves insulin sensitivity in ovariectomized rats
Urtado CB, Pereira GB, Urtado MB, Carvalho EB, Leite GS, Donatto FF, Assumpção CO, Leite RD, Silva CA, Sales MM, Tibana RA, Alves SCC, Prestes J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:385-391
Published Date: 22 November 2011
Glycemic control and anti-osteopathic effect of propolis in diabetic rats
Al-Hariri M, Gamal Eldin T, Abu-Hozaifa B, Elnour A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:377-384
Published Date: 22 November 2011
Clinical and behavioral factors associated with management outcome in hospitalized patients with diabetic foot ulcer
Yekta Z, Pourali R, Nezhadrahim R, Ravanyar L, Ghasemi-rad M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:371-375
Published Date: 13 October 2011
Management of diabetes across the course of disease: minimizing obesity-associated complications
Apovian CM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:353-369
Published Date: 12 October 2011
Morning cortisol is lower in obese individuals with normal glucose tolerance
Praveen EP, Sahoo JP, Kulshreshtha B, Khurana ML, Gupta N, Dwivedi SN, Kumar G, Ammini AC
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:347-352
Published Date: 7 September 2011
Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach
Kedia N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:337-346
Published Date: 6 September 2011
Primary infragenicular angioplasty for diabetic neuroischemic foot ulcers following the angiosome distribution: a new paradigm for the vascular interventionist?
Alexandrescu V, Hubermont G
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:327-336
Published Date: 22 August 2011
Corrigendum
Bovet P, Hirsiger P, Emery F, De Bernardini J, Rossier C, Trebeljahr J, Hagon-Traub I
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:325-326
Published Date: 17 August 2011
Effect of weight loss on adipokine levels in obese patients
Rolland C, Hession M, Broom I
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:315-323
Published Date: 3 August 2011
Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study
Garfinkel D, Zorin M, Wainstein J, Matas Z, Laudon M, Zisapel N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:307-313
Published Date: 2 August 2011
Update on the management of diabetic polyneuropathies
Shakher J, Stevens MJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:289-305
Published Date: 21 July 2011
Two-way crossover comparison of insulin glargine and insulin detemir in basal-bolus therapy using continuous glucose monitoring
Abe S, Inoue G, Yamada S, Irie J, Nojima H, Tsuyusaki K, Usui K, Atsuda K, Yamanouchi T
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:283-288
Published Date: 13 July 2011
Is obesity in women protective against osteoporosis?
Migliaccio S, Greco EA, Fornari R, Donini LM, Lenzi A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:273-282
Published Date: 4 July 2011
Patient considerations and clinical utility of a fixed dose combination of saxagliptin/metformin in the treatment of type 2 diabetes
Derosa G, Maffioli P
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:263-271
Published Date: 30 June 2011
Insulin initiation and intensification in patients with T2DM for the primary care physician
Unger J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:253-261
Published Date: 28 June 2011
Perception of weight and psychological variables in a sample of Spanish adolescents
Jáuregui-Lobera I, Bolaños-Ríos P, Santiago-Fernández MJ, Garrido-Casals O, Sánchez E
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:245-251
Published Date: 24 June 2011
Predictors of weight loss and maintenance in patients treated with antiobesity drugs
Guaraldi F, Pagotto U, Pasquali R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:229-243
Published Date: 20 June 2011
Central adiposity and the propensity for rehearsal in children
Ling FCM, Masters RSW, Yu CCW, McManus AM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:225-228
Published Date: 17 June 2011
Impact and cost of a 2-week community-based screening and awareness program for diabetes and cardiovascular risk factors in a Swiss canton
Bovet P, Hirsiger P, Emery F, De Bernardini J, Rossier C, Trebeljahr J, Hagon-Traub I
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:213-223
Published Date: 16 June 2011
Is vitamin D status a determining factor for metabolic syndrome? A case-control study
Salekzamani S, Neyestani TR, Alavi-Majd H, Houshiarrad A, Kalayi A, Shariatzadeh N, Gharavi A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:205-212
Published Date: 10 June 2011
Diet-induced metabolic hamster model of nonalcoholic fatty liver disease
Bhathena J, Kulamarva A, Martoni C, Urbanska A, Malhotra M, Paul A, Prakash S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:195-203
Published Date: 3 June 2011
Cardiometabolic results from an armband-based weight loss trial
Sieverdes JC, Sui X, Hand GA, Barry VW, Wilcox S, Meriwether RA, Hardin JW, McClain AC, Blair SN
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:187-194
Published Date: 30 May 2011
New onset diabetes after transplantation (NODAT): an overview
Pham PT, Pham PM, Pham SV, Pham PA, Pham PC
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:175-186
Published Date: 9 May 2011
Effects of a moderate low-carbohydrate diet on preferential abdominal fat loss and cardiovascular risk factors in patients with type 2 diabetes
Sasakabe T, Haimoto H, Umegaki H, Wakai K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:167-174
Published Date: 29 April 2011
Treating statin-intolerant patients
Arca M, Pigna G
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:155-166
Published Date: 28 April 2011
Strategies for reducing body fat mass: effects of liposuction and exercise on cardiovascular risk factors and adiposity
Benatti FB, Lira FS, Oyama LM, Oller do Nascimento CM, Lancha AH Jr
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:141-154
Published Date: 20 April 2011
Antidiabetic effect of glucosaminic acid-cobalt (II) chelate in streptozotocin-induced diabetes in mice
Talba T, Shui XW, Cheng QY, Tian X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:137-140
Published Date: 18 April 2011
Patient perceptions of treatment and illness when prescribed multiple medicines for co-morbid type 2 diabetes
Stack RJ, Bundy C, Elliott RA, New JP, Gibson JM, Noyce PR
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:127-135
Published Date: 11 April 2011
Relationship between sleep duration and clustering of metabolic syndrome diagnostic components
Katano S, Nakamura Y, Nakamura A, Murakami Y, Tanaka T, Takebayashi T, Okayama A, Miura K, Okamura T, Ueshima H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:119-125
Published Date: 4 April 2011
Awareness of Abdominal Adiposity as a Cardiometabolic Risk Factor (The 5A Study): Mexico
Cuevas-Ramos D, Mehta R, De La Luz-Castro J, Garcia-Rubi E, Aguilar-Salinas CA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:107-117
Published Date: 28 March 2011
Morbid obesity and metabolic syndrome in Ossabaw miniature swine are associated with increased platelet reactivity
Rolf P Kreutz, Mouhamad Alloosh, Khaled Mansour, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:99-105
Published Date: 15 March 2011
Strategy to combat obesity and to promote physical activity in Arab countries
Abdulrahman O Musaiger, Hazzaa M Al Hazzaa, Aayed Al-Qahtani, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:89-97
Published Date: 8 March 2011
Cost effectiveness and cost utility of the noncoding blood glucose meter CONTOUR® TS
Przemyslaw Holko, Pawal Kawalec
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:79-88
Published Date: 10 February 2011
Using a technology-based intervention to promote weight loss in sedentary overweight or obese adults: a randomized controlled trial study design
Vaughn W Barry, Amanda C McClain, Sara Shuger, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:67-77
Published Date: 4 February 2011
Exenatide improves glucocorticoid-induced glucose intolerance in mice
Ruiying Zhao, Enrique Fuentes-Mattei, Guermarie Velazquez-Torres, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:61-65
Published Date: 26 January 2011
Effects of zinc and multimineral vitamin supplementation on glycemic and lipid control in adult diabetes
Priyanka Gunasekara, Manjula Hettiarachchi, Chandrani Liyanage, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:53-60
Published Date: 26 January 2011
Association of adiponectin levels and insulin demand in critically ill patients
Andreas Hillenbrand, Manfred Weiss, Uwe Knippschild, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:45-51
Published Date: 26 January 2011
Relationships between fat deposition in the liver and skeletal muscle and insulin sensitivity in Japanese individuals: a pilot study
Eiichi Yoshimura, Hideaki Kumahara, Takuro Tobina, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:35-43
Published Date: 20 January 2011
Carotid intima-media thickness as a surrogate marker of cardiovascular disease in diabetes
Latika Sibal, Sharad C Agarwal, Philip D Home
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:23-34
Published Date: 19 January 2011
Increasing effect of body weight perception on suicidal ideation among young Korean women: Findings from the Korea National Health and Nutrition Examination Survey 2001 and 2005
Dong-Sik Kim
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:17-22
Published Date: 11 January 2011
TRC150094 attenuates progression of nontraditional cardiovascular risk factors associated with obesity and type 2 diabetes in obese ZSF1 rats
Shitalkumar P Zambad, Siralee Munshi, Amita Dubey, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:5-16
Published Date: 6 January 2011
Risk factors associated with metabolic syndrome in type 2 diabetes mellitus patients according to World Health Organization, Third Report National Cholesterol Education Program, and International Diabetes Federation definitions
Angel Rodríguez, Helena Delgado-Cohen, Jesús Reviriego, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:1-4
Published Date: 16 December 2010
Topiramate improves neurovascular function, epidermal nerve fiber morphology, and metabolism in patients with type 2 diabetes mellitus
Amanda L Boyd, Patricia M Barlow, Gary L Pittenger, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:431-437
Published Date: 6 December 2010
Curcumin improves prostanoid ratio in diabetic mesenteric arteries associated with cyclooxygenase-2 and NF-κB suppression
Sirada Rungseesantivanon, Naris Thengchaisri, Preecha Ruangvejvorachai, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:421-429
Published Date: 6 December 2010
Serum ferritin concentration in gestational diabetes mellitus and risk of subsequent development of early postpartum diabetes mellitus
Faranak Sharifi, Amir Ziaee, Abdolamir Feizi, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:413-419
Published Date: 1 December 2010
The role of insulin glulisine to improve glycemic control in children with diabetes mellitus
Anna Lih, Emily Hibbert, Tang Wong, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:403-412
Published Date: 26 November 2010
Anthropometric cutoff values for detecting metabolic abnormalities in Jordanian adults
Yousef S Khader, Anwar Batieha, Hashim Jaddou, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:395-402
Published Date: 18 November 2010
Achievement of cardiovascular risk factor targets in young adults with diabetes mellitus
Peter J Donovan, H David McIntyre
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:387-394
Published Date: 16 November 2010
Lifestyle modification in the management of the metabolic syndrome: achievements and challenges
Riccardo Dalle Grave, Simona Calugi, Elena Centis, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:373-385
Published Date: 2 November 2010
Clinical utility of fixed combinations of sitagliptin–metformin in treatment of type 2 diabetes
Karen Barnard, Mary Elizabeth Cox, Jennifer B Green
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:363-372
Published Date: 27 October 2010
Effect of a low-carbohydrate diet versus a low-fat, calorie-restricted diet on adipokine levels in obese, diabetic participants
Marion L Vetter, Alisha Wade, Leslie G Womble, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:357-361
Published Date: 13 October 2010
Evaluation of single nucleotide polymorphisms of Pro12Ala in peroxisome proliferator-activated receptor-γ and Gly308Ala in tumor necrosis factor-α genes in obese Asian Indians: a population-based study
Namita Bhagat, Mukta Agrawal, Kalpana Luthra, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:349-356
Published Date: 11 October 2010
Imaging body composition in obesity and weight loss: challenges and opportunities
Heidi J Silver, E Brian Welch, Malcolm J Avison, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:337-347
Published Date: 28 September 2010
Saxagliptin for type 2 diabetes
Antonio R Chacra, MD
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:325-335
Published Date: 22 September 2010
Disturbance of inorganic phosphate metabolism in diabetes mellitus: clinical manifestations of phosphorus-depletion syndrome during recovery from diabetic ketoacidosis
Jørn Ditzel, Hans-Henrik Lervang
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:319-324
Published Date: 20 September 2010
Anorexia nervosa depends on adrenal sympathetic hyperactivity: opposite neuroautonomic profile of hyperinsulinism syndrome
Fuad Lechin, Bertha van der Dijs, Betty Pardey-Maldonado, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:311-317
Published Date: 9 September 2010
Beta-cell function is associated with metabolic syndrome in Mexican subjects
Blanca G Baez-Duarte, Maria Del Carmen Sanchez-Guillen, Ricardo Perez-Fuentes, et al.
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:301-309
Published Date: 30 August 2010
Optimizing weight control in diabetes: antidiabetic drug selection
S Kalra, B Kalra, AG Unnikrishnan, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:297-299
Published Date: 24 August 2010
The economic impact of obesity in the United States
Ross A Hammond, Ruth Levine
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:285-295
Published Date: 30 August 2010
Outcomes of Roux-en-Y gastric bypass surgery for severely obese patients with type 1 diabetes: a case series report
Carlos E Mendez, Robert J Tanenberg, Walter Pories
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:281-283
Published Date: 10 August 2010
Aerobic training increases skin perfusion by a nitric oxide mechanism in type 2 diabetes
Sheri R Colberg, Laura C Hill, Henri K Parson, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:275-280
Published Date: 4 August 2010
Emerging role of GLP-1 receptor agonists in the treatment of obesity
Lisa M Neff, Robert F Kushner
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:263-273
Published Date: 20 July 2010
Obesity and the development of type 2 diabetes: the effects of fatty tissue inflammation
Dara P Schuster
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:253-262
Published Date: 16 July 2010
Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin
Stanley S Schwartz
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:243-252
Published Date: 9 July 2010
Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
Stanley Schwartz, Benjamin A Kohl
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:227-242
Published Date: 9 July 2010
Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes
Joshua J Neumiller, Travis E Sonnett, Lindy D Wood, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:215-226
Published Date: 14 July 2010
Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics
Jean-Pierre Le Floch
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:197-213
Published Date: 21 June 2010
High-sensitivity C-reactive protein concentrations among patients with and without diabetes in a multiethnic population of Singapore: CREDENCE Study
Rinkoo Dalan, Michelle Jong, Siew-Pang Chan, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:187-195
Published Date: 22 June 2010
Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention
Alaa Badawi, Amira Klip, Pierre Haddad, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:173-186
Published Date: 26 May 2010
Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus
Jason Seewoodhary, Leanne Griffin, Stephen C Bain
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:165-172
Published Date: 17 May 2010
Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes – a review
Katrine B Hansen, Tina Vilsbøll, Filip K Knop
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:155-163
Published Date: 17 May 2010
Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update
Robert G Moses
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:145-154
Published Date: 10 May 2010
The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agents
Sonia A Tucci, Emma J Boyland, Jason CG Halford
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:125-143
Published Date: 10 May 2010
New treatments in the management of type 2 diabetes: a critical appraisal of saxagliptin
Baptist Gallwitz
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:117-124
Published Date: 10 May 2010
Leukocyte peroxidase and leptin: an associated link of glycemic tolerance and bronchial asthma?
Sergio Parco
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:113-116
Published Date: 11 May 2010
Tackling obesity: new therapeutic agents for assisted weight loss
JG Karam, SI McFarlane
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:95-112
Published Date: 26 April 2010
Effect of Holostemma annularis on the progression of diabetes induced by a high fructose diet in rats and in diabetic C57BL/6J ob/ob mice
Sudharshan Reddy D, Muchandi IS, Srinivasa Rao A, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:87-94
Published Date: 26 April 2010
Significant increment in the prevalence of overweight and obesity documented between 1994 and 2008 in Mexican college students
H García-Alcala, D Cuevas-Ramos, Ch Genestier-Tamborero, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:79-85
Published Date: 19 April 2010
Prolylcarboxypeptidase (PRCP) as a new target for obesity treatment
B Shariat-Madar, D Kolte, A Verlangieri, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:67-78
Published Date: 19 April 2010
Past, present, and future: Critical analysis of use of gastric bands in obese patients
Brad Snyder, Todd Wilson, Sheilendra Mehta, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:55-65
Published Date: 1 April 2010
Minimizing the risk of hypoglycemia in patients with type 2 diabetes mellitus
Pamela Kushner
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:49-53
Published Date: 13 April 2010
Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes
Michael A Via, Himani Chandra, Takako Araki, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:43-48
Published Date: 26 March 2010
Use of DPP-4 inhibitors in type 2 diabetes: focus on sitagliptin
Bo Ahrén
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:31-41
Published Date: 29 March 2010
A psychometric evaluation of the Diabetes Symptom Checklist-Revised (DSC-R) cognitive distress, fatigue, hyperglycemia, and hypoglycemia subscales in patients with type 1 and type 2 diabetes
April N Naegeli, Timothy E Stump, Risa P Hayes
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:27-30
Published Date: 9 March 2010
Pleiotropic effects of rosuvastatin on microvascular function in type 2 diabetes
Henri K Parson, Meredith A Bundy, Charlotte B Dublin, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:19-26
Published Date: 25 January 2010
Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine
Lindsay Zilliox, James W Russell
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:7-17
Published Date: 6 January 2010
A molecular mechanism for diacylglycerol-mediated promotion of negative caloric balance
Hidekatsu Yanai, Yoshiharu Tomono, Kumie Ito, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:1-6
Published Date: 18 December 2009
Amantadine reduces glucagon and enhances insulin secretion throughout the oral glucose tolerance test: central plus peripheral nervous system mechanisms
Fuad Lechin, Bertha van der Dijs, Betty Pardey-Maldonado, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:203-213
Published Date: 2 December 2009
Management of obesity, insulin resistance and type 2 diabetes in children: consensus and controversy
Amy Fleischman, Erinn T Rhodes
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:185-202
Published Date: 27 November 2009
Impact of obesity and type 2 diabetes on health-related quality of life in the general population in England
Stephen CL Gough, Nana Kragh, Uffe Jon Ploug, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:179-184
Published Date: 3 November 2009
Disturbance of inorganic phosphate metabolism in diabetes mellitus: temporary therapeutic intervention trials
Jørn Ditzel, Hans Henrik Lervang
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:173-177
Published Date: 8 October 2009
Peroxisome proliferator-activated receptors as stimulants of angiogenesis in cardiovascular disease and diabetes
Cyrus V Desouza, Lindsey Rentschler, Vivian Fonseca
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:165-172
Published Date: 25 September 2009
Self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview
Nanne Kleefstra, Johanna Hortensius, Kornelis JJ van Hateren, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:155-163
Published Date: 9 September 2009
Potential efficacy of preparations derived from Phaseolus vulgaris in the control of appetite, energy intake, and carbohydrate metabolism
Mauro AM Carai, Noemi Fantini, Barbara Loi, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:145-153
Published Date: 7 September 2009
Recent results of exenatide use as adjunctive therapy in the treatment of patients with type 2 diabetes
Peggy Soule Odegard, Anthony DeSantis
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:135-144
Published Date: 31 July 2009
Fixed-dose combination of sitagliptin and metformin for the treatment of type 2 diabetes
Jonathan K Reynolds
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:127-134
Published Date: 30 July 2009
Alogliptin: a new addition to the class of DPP-4 inhibitors
Radha Andukuri, Andjela Drincic, Marc Rendell
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:117-126
Published Date: 21 July 2009
Insulin glulisine in the management of diabetes
Satoru Yamada
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:111-115
Published Date: 7 July 2009
Fixed combination of repaglinide and metformin in the management of type 2 diabetes
Robert Moses
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:101-109
Published Date: 24 June 2009
p38 MAPK inhibition reduces diabetes-induced impairment of wound healing
Satyanarayana Medicherla, Scott Wadsworth, Breda Cullen, Derek Silcock, et al.
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:91-100
Published Date: 23 June 2009
Inhibition of dipeptidyl peptidase-4: The mechanisms of action and clinical use of vildagliptin for the management of type 2 diabetes
Galina Smushkin, Adrian Vella
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:83-90
Published Date: 12 June 2009
Management of gestational diabetes mellitus
Annunziata Lapolla, Maria Grazia Dalfrà, Domenico Fedele
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:73-82
Published Date: 17 June 2009
Biphasic insulin aspart 30/70 (BIAsp 30) in the treatment of type 1 and type 2 diabetes
Paul Valensi
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:61-71
Published Date: 3 June 2009
Risk management in the treatment of type 2 diabetes with pioglitazone
Giuseppe Derosa, Sibilla AT Salvadeo
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:51-60
Published Date: 1 July 2009
Role and development of GLP-1 receptor agonists in the management of diabetes
Chee W Chia, Josephine M Egan
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:37-49
Published Date: 18 May 2009
Analog insulin detemir for patients with type 1 and type 2 diabetes: a review
Gregory E Peterson
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:31-36
Published Date: 15 May 2009
Sitagliptin as combination therapy in the treatment of type 2 diabetes mellitus
Shannon A Miller, Erin L St Onge, J Roger Accardi
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:23-30
Published Date: 13 May 2009
Improving glycemic and cholesterol control through an integrated approach incorporating colesevelam – a clinical perspective
Ronald B Goldberg
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:11-21
Published Date: 5 May 2009
Assessing the impact of a new delivery method of insulin on glycemic control using a novel trial design
Thomas Strack, Luc Martinez, Stefano Del Prato, Larry Blonde, Burkhard Göke, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:1-10
Published Date: 20 January 2009
Comorbidity and glycemia control among patients with type 2 diabetes in primary care
Catherine Hudon, Martin Fortin, Marie-France Dubois, José Almirall
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2008, 1:33-37
Published Date: 18 November 2008
Adipose inflammation: cause or consequence of obesity-related insulin resistance
Ping Jiao, Haiyan Xu
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2008, 1:25-31
Published Date: 23 October 2008
Assessing the effect of weight and weight loss in obese persons with type 2 diabetes
Bradley Curtis, Risa P Hayes, Sheri Fehnel, Laurie Zografos
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2008, 1:13-23
Published Date: 14 October 2008
The route to diabetes: Loss of complexity in the glycemic profile from health through the metabolic syndrome to type 2 diabetes
Juan Churruca, Luis Vigil, Esther Luna, Julian Ruiz-Galiana, Manuel Varela
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2008, 1:3-11
Published Date: 11 August 2008
Insulin autoimmune syndrome in a patient with ANCA-associated glomerulonephritis
Tsuneyoshi Ka, Yuji Moriwaki, Takeshi Nakanishi, Tetsuya Yamamoto
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2008, 1:1-2
Published Date: 19 June 2008